This inventor holds 1 USPTO granted patent. Top assignees: Accendatech, Nankai University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2019
Title: **Bin Han: Innovator in Drug Technology**
Introduction
Bin Han is an accomplished inventor based in Tianjin, China. He has made significant contributions to the field of drug technology, with a focus on the applications of sesquiterpene lactone compounds. His innovative work is aimed at improving treatments for serious health conditions such as rheumatoid arthritis and certain cancers.
Latest Patents
Han holds a notable patent titled "Uses of sesquiterpene lactone compounds and their derivatives in drugs preparation." This invention relates to the use of specific compounds in the formulation of drugs, particularly those that target cancer stem cells. The technology highlights the potential of sesquiterpene lactones in developing effective treatments for debilitating diseases.
Career Highlights
Throughout his career, Bin Han has been associated with esteemed organizations, including Accendatech and Nankai University. His work at these institutions has allowed him to collaborate with talented individuals and to further his research in drug technology.
Collaborations
In his professional journey, Han has worked alongside notable colleagues such as Yue Chen and Quan Zhang. These collaborations have contributed to the advancement of his research and the successful application of his patented technologies in the medical field.
Conclusion
In summary, Bin Han's innovative contributions to drug technology, particularly through his patent on sesquiterpene lactone compounds, demonstrate his commitment to advancing healthcare solutions. His career and collaborations reflect the potential of his inventions to make a significant impact on the treatment of critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile